GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elbit Imaging Ltd (OTCPK:EMITF) » Definitions » Sloan Ratio %

Elbit Imaging (Elbit Imaging) Sloan Ratio % : -31.17% (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Elbit Imaging Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Elbit Imaging's Sloan Ratio for the quarter that ended in Dec. 2023 was -31.17%.

Warning Sign:

When sloan ratio (-31.18)% higher than 25% or lower than -25%, earnings are more likely to be made up of accruals.

As of Dec. 2023, Elbit Imaging has a Sloan Ratio of -31.17%, indicating earnings are more likely to be made up of accruals.


Elbit Imaging Sloan Ratio % Historical Data

The historical data trend for Elbit Imaging's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elbit Imaging Sloan Ratio % Chart

Elbit Imaging Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -73.01 116.21 -56.32 -32.44 -31.18

Elbit Imaging Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -56.32 -45.31 -32.43 -45.34 -31.17

Competitive Comparison of Elbit Imaging's Sloan Ratio %

For the Medical Devices subindustry, Elbit Imaging's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elbit Imaging's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elbit Imaging's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Elbit Imaging's Sloan Ratio % falls into.



Elbit Imaging Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Elbit Imaging's Sloan Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2023 )-Cash Flow from Operations (A: Dec. 2023 )
-Cash Flow from Investing (A: Dec. 2023 ))/Total Assets (A: Dec. 2023 )
=(-4.831--0.786
-1.251)/16.984
=-31.18%

Elbit Imaging's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-4.83--0.787
-1.251)/16.984
=-31.17%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Elbit Imaging's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -2.56 (Jun. 2023 ) + -2.27 (Dec. 2023 ) = $-4.83 Mil.
Elbit Imaging's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -0.415 (Jun. 2023 ) + -0.372 (Dec. 2023 ) = $-0.79 Mil.
Elbit Imaging's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was 0.502 (Jun. 2023 ) + 0.749 (Dec. 2023 ) = $1.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elbit Imaging  (OTCPK:EMITF) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Elbit Imaging has a Sloan Ratio of -31.17%, indicating earnings are more likely to be made up of accruals.


Elbit Imaging Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Elbit Imaging's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elbit Imaging (Elbit Imaging) Business Description

Traded in Other Exchanges
Address
3 Shimshon Street, Olympia A Tower, Petach Tikva, ISR, 4900102
Elbit Imaging Ltd is an Israel based company. The business activity of the group is operated through two segments including Medical industries and devices, and Plots in India. Geographically the business presence is in the region of America, Europe, and ROW. The company derives maximum revenue from the Medical industries and devices segment which operates in the field of life science that includes development, production, and marketing of treatment-oriented medical systems, and for certain cancer diseases in the America region.

Elbit Imaging (Elbit Imaging) Headlines

From GuruFocus